Company Filing History:
Years Active: 2013-2015
Title: Naomi Harwood: Innovator in T Cell Receptor Technology
Introduction
Naomi Harwood is a prominent inventor based in Oxfordshire, GB. She has made significant contributions to the field of immunology, particularly in the development of non-naturally occurring T cell receptors. With a total of 2 patents, her work is paving the way for advancements in adoptive therapy.
Latest Patents
Harwood's latest patents include groundbreaking inventions related to nucleic acid molecules encoding T cell receptors. One of her notable patents describes a T cell receptor (TCR) that binds to the gp100 YLEPGPVTA peptide-HLA-A2 complex. This TCR is characterized by mutated domains relative to a reference TCR, providing enhanced binding affinity and half-life. The patent also discusses the potential use of these TCRs in adoptive therapy and their fusion with therapeutic agents.
Career Highlights
Naomi Harwood has established herself as a key figure in her field through her innovative research and development efforts. Her work at Immunocore Limited has been instrumental in advancing T cell receptor technology, which holds promise for cancer treatment and other therapeutic applications.
Collaborations
Harwood collaborates with esteemed colleagues such as Bent Karsten Jakobsen and Nathanial Ross Liddy. These partnerships enhance the research and development of T cell receptor technologies, contributing to the overall success of their projects.
Conclusion
Naomi Harwood's contributions to T cell receptor technology exemplify her dedication to innovation in immunology. Her patents and collaborative efforts are set to make a lasting impact on therapeutic strategies in the medical field.